ARAY
Price
$1.63
Change
-$0.04 (-2.40%)
Updated
May 17, 6:59 PM EST
89 days until earnings call
ATRC
Price
$23.14
Change
+$0.51 (+2.25%)
Updated
May 17, 6:59 PM EST
73 days until earnings call
Ad is loading...

ARAY vs ATRC

Header iconARAY vs ATRC Comparison
Open Charts ARAY vs ATRCBanner chart's image
Accuray
Price$1.63
Change-$0.04 (-2.40%)
Volume$341.11K
CapitalizationN/A
AtriCure
Price$23.14
Change+$0.51 (+2.25%)
Volume$297.22K
CapitalizationN/A
View a ticker or compare two or three
ARAY vs ATRC Comparison Chart

Loading...

ARAYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ATRCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ARAY vs. ATRC commentary
May 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAY is a StrongBuy and ATRC is a Buy.

COMPARISON
Comparison
May 18, 2024
Stock price -- (ARAY: $1.63 vs. ATRC: $23.14)
Brand notoriety: ARAY and ATRC are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ARAY: 76% vs. ATRC: 67%
Market capitalization -- ARAY: $244.95M vs. ATRC: $1.45B
ARAY [@Medical Specialties] is valued at $244.95M. ATRC’s [@Medical Specialties] market capitalization is $1.45B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.49B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARAY’s FA Score shows that 0 FA rating(s) are green whileATRC’s FA Score has 0 green FA rating(s).

  • ARAY’s FA Score: 0 green, 5 red.
  • ATRC’s FA Score: 0 green, 5 red.
According to our system of comparison, ARAY is a better buy in the long-term than ATRC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARAY’s TA Score shows that 5 TA indicator(s) are bullish while ATRC’s TA Score has 5 bullish TA indicator(s).

  • ARAY’s TA Score: 5 bullish, 3 bearish.
  • ATRC’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both ARAY and ATRC are a good buy in the short-term.

Price Growth

ARAY (@Medical Specialties) experienced а +0.62% price change this week, while ATRC (@Medical Specialties) price change was +3.77% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.34%. For the same industry, the average monthly price growth was +4.51%, and the average quarterly price growth was +16.96%.

Reported Earning Dates

ARAY is expected to report earnings on Aug 15, 2024.

ATRC is expected to report earnings on Jul 30, 2024.

Industries' Descriptions

@Medical Specialties (+2.34% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for ARAY with price predictions.
OPEN
A.I.dvisor published
a Summary for ATRC with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ATRC($1.45B) has a higher market cap than ARAY($245M). ATRC YTD gains are higher at: -35.164 vs. ARAY (-42.403). ARAY has higher annual earnings (EBITDA): 5.93M vs. ATRC (-8.11M). ATRC has more cash in the bank: 137M vs. ARAY (72.8M). ATRC has less debt than ARAY: ATRC (74.5M) vs ARAY (202M). ARAY has higher revenues than ATRC: ARAY (447M) vs ATRC (399M).
ARAYATRCARAY / ATRC
Capitalization245M1.45B17%
EBITDA5.93M-8.11M-73%
Gain YTD-42.403-35.164121%
P/E RatioN/A36.76-
Revenue447M399M112%
Total Cash72.8M137M53%
Total Debt202M74.5M271%
FUNDAMENTALS RATINGS
ARAY vs ATRC: Fundamental Ratings
ARAY
ATRC
OUTLOOK RATING
1..100
710
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9692
PRICE GROWTH RATING
1..100
9182
P/E GROWTH RATING
1..100
5095
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATRC's Valuation (67) in the Medical Specialties industry is in the same range as ARAY (83). This means that ATRC’s stock grew similarly to ARAY’s over the last 12 months.

ATRC's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ARAY (100). This means that ATRC’s stock grew similarly to ARAY’s over the last 12 months.

ATRC's SMR Rating (92) in the Medical Specialties industry is in the same range as ARAY (96). This means that ATRC’s stock grew similarly to ARAY’s over the last 12 months.

ATRC's Price Growth Rating (82) in the Medical Specialties industry is in the same range as ARAY (91). This means that ATRC’s stock grew similarly to ARAY’s over the last 12 months.

ARAY's P/E Growth Rating (50) in the Medical Specialties industry is somewhat better than the same rating for ATRC (95). This means that ARAY’s stock grew somewhat faster than ATRC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARAYATRC
RSI
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
65%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 1 day ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 10 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
ARAYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ATRCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IBSSX23.770.13
+0.55%
VY® Baron Growth S
OTCNX65.820.06
+0.09%
Invesco Capital Appreciation R
MFWTX17.680.01
+0.06%
MFS Global Total Return A
MMNFX6.63N/A
N/A
MassMutual Growth Opps Y
WIREX17.10-0.07
-0.41%
Wireless

ARAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with BRKR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then BRKR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
-2.40%
BRKR - ARAY
41%
Loosely correlated
-0.99%
TFX - ARAY
40%
Loosely correlated
-0.43%
LH - ARAY
38%
Loosely correlated
-1.19%
XRAY - ARAY
38%
Loosely correlated
-0.35%
LUNG - ARAY
37%
Loosely correlated
-0.55%
More

ATRC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with VCYT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
+2.25%
VCYT - ATRC
47%
Loosely correlated
-2.22%
TFX - ATRC
47%
Loosely correlated
-0.43%
MDT - ATRC
43%
Loosely correlated
+0.33%
STE - ATRC
41%
Loosely correlated
+0.85%
PEN - ATRC
41%
Loosely correlated
+0.99%
More